|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/18 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61B 5/055 | (2006.01) |
| (11) | Number of the document | 3525583 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17859451.1 |
| Date of filing the European patent application | 2017-10-12 | |
| (97) | Date of publication of the European application | 2019-08-21 |
| (45) | Date of publication and mention of the grant of the patent | 2025-07-23 |
| (46) | Date of publication of the claims translation | 2025-11-10 |
| (86) | Number | PCT/US2017/056349 |
| Date | 2017-10-12 |
| (87) | Number | WO 2018/071676 |
| Date | 2018-04-19 |
| (30) | Number | Date | Country code |
| 201662407390 P | 2016-10-12 | US |
| (72) |
PANICKER, Sandip , US
PARRY, Graham , US
STAGLIANO, Nancy, E. , US
|
| (73) |
Bioverativ USA Inc. ,
225 Second Avenue, Waltham, MA 02451,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Anti-C1S antikūnai ir jų naudojimo būdai |
| ANTI-C1S ANTIBODIES AND METHODS OF USE THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-10-10 | 9 | 208.00 EUR |
| 2026-10-12 |